Filing Details

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

 

SCHEDULE 13D/A

 

INFORMATION TO BE INCLUDED IN STATEMENT FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

§ 240.13d-2(a)

 

(Amendment No. 10)*

 

Castle Brands Inc.

(Name of Issuer)

 

Common Stock, par value $0.01 per share

(Title of Class of Securities)

 

148435100

(CUSIP Number)

 

Steven D. Rubin

4400 Biscayne Boulevard, Suite 1500

Miami, Florida 33137

Telephone: (305) 575-6015

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

March 1, 2018

(Date of Event Which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [  ].

 

Note. Schedules filed in paper format shall include a signed original and five copies of the Schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 148435100

13D/A

Page 2 of 7 Pages

 

1	Names of Reporting Persons   Phillip Frost, M.D.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)   (a) [  ] (b) [  ]
3	SEC USE ONLY
4	SOURCE OF FUNDS (see instructions)   OO
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)   [  ]
6	CITIZENSHIP OR PLACE OF ORGANIZATION   United States of America

NUMBER OF	7	SOLE VOTING POWER   874,776 (1)
SHARES BENEFICIALLY OWNED BY EACH	8	SHARED VOTING POWER   53,271,509 (2)(3)
REPORTING PERSON WITH	9	SOLE DISPOSITIVE POWER   874,776 (1)
	10	SHARED DISPOSITIVE POWER   53,271,509 (2)(3)

11	Aggregate Amount Beneficially Owned by Each Reporting Person   54,146,285 (1)(2)(3)
12	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)   [  ]
13	Percent of Class Represented by Amount in Row 11   32.6% (4)
14	Type of Reporting Person (see instructions)   IN

 

(1) Includes (i) vested options (including options that will be exercisable within 60 days of the date hereof) to purchase 80,000 Common Shares (as defined herein) and (ii) 15,000 restricted Common Shares granted to Frost (as defined herein) on March 1, 2018, which will vest in two equal annual installments, beginning on the one year anniversary of the date of grant.

 

(2) Includes 43,900,719 Common Shares held by the Gamma Trust (as defined herein).

 

(3) Includes 9,370,790 Common Shares held by the Nevada Trust (as defined herein).

 

(4) The calculation of the percentage is based on (i) 166,141,838 Common Shares outstanding as of February 7, 2018, as reported on the 10-Q filed on February 9, 2018, (ii) 80,000 Common Shares to be issued upon the exercise of vested options (including options that will be exercisable within 60 days of the date hereof) held by the Reporting Person and (iii) 15,000 restricted Common Shares granted to Frost on March 1, 2018, which will vest in two equal annual installments, beginning on the one year anniversary of the date of grant.

 

 

CUSIP No. 148435100

13D/A

Page 3 of 7 Pages

 

1	Names of Reporting Persons   Frost Gamma Investments Trust
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)   (a) [  ] (b) [  ]
3	SEC USE ONLY
4	SOURCE OF FUNDS (see instructions)   WC
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)   [  ]
6	CITIZENSHIP OR PLACE OF ORGANIZATION   Florida

NUMBER OF	7	SOLE VOTING POWER   0
SHARES BENEFICIALLY OWNED BY EACH	8	SHARED VOTING POWER   43,900,719
REPORTING PERSON WITH	9	SOLE DISPOSITIVE POWER   0
	10	SHARED DISPOSITIVE POWER   43,900,719

11	Aggregate Amount Beneficially Owned by Each Reporting Person   43,900,719
12	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)   [  ]
13	Percent of Class Represented by Amount in Row 11   26.4% (1)
14	Type of Reporting Person (see instructions)   OO

 

(1) The calculation of the percentage is based on 166,141,838 Common Shares outstanding as of February 7, 2018, as reported on the 10-Q filed on February 9, 2018.

 

 

CUSIP No. 148435100

13D/A

Page 4 of 7 Pages

 

1	Names of Reporting Persons   Frost Nevada Investments Trust
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)   (a) [  ] (b) [  ]
3	SEC USE ONLY
4	SOURCE OF FUNDS (see instructions)   WC
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)   [  ]
6	CITIZENSHIP OR PLACE OF ORGANIZATION   Florida

NUMBER OF	7	SOLE VOTING POWER   0
SHARES BENEFICIALLY OWNED BY EACH	8	SHARED VOTING POWER   9,370,790
REPORTING PERSON WITH	9	SOLE DISPOSITIVE POWER   0
	10	SHARED DISPOSITIVE POWER   9,370,790

11	Aggregate Amount Beneficially Owned by Each Reporting Person   9,370,790
12	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)   [  ]
13	Percent of Class Represented by Amount in Row 11   5.6% (1)
14	Type of Reporting Person (see instructions)   OO

 

(1) The calculation of the percentage is based on 166,141,838 Common Shares outstanding as of February 7, 2018, as reported on the 10-Q filed on February 9, 2018.

 

 

CUSIP No. 148435100

13D/A

Page 5 of 7 Pages

 

SCHEDULE 13D/A

 

AMENDMENT NO. 10 TO SCHEDULE 13D

 

This Amendment No. 10 to Schedule 13D (this “Amendment”) amends certain Items of the Schedule 13D (the “Original 13D”) filed by Phillip Frost, M.D., an individual (“Frost”), Frost Gamma Investments Trust, a trust organized under the laws of Florida (the “Gamma Trust”), and Frost Nevada Investments Trust, a trust organized under the laws of Florida (the “Nevada Trust”, and together with the Gamma Trust, the “Trusts”; and the Trusts, together with Frost, each a “Reporting Person” and together the “Reporting Persons”) with the Securities and Exchange Commission (the “SEC”) on September 15, 2008, as amended by Amendment No. 1 to Schedule 13D filed on October 22, 2008 with the SEC, Amendment No. 2 to Schedule 13D filed on February 20, 2009 with the SEC, Amendment No. 3 to Schedule 13D filed on May 27, 2009, Amendment No. 4 to Schedule 13D filed on July 6, 2010, Amendment No. 5 to Schedule 13D filed on June 20, 2011, Amendment No. 6 to Schedule 13D filed on October 27, 2011, Amendment No. 7 to Schedule 13D filed on March 14, 2014, Amendment No. 8 to Schedule 13D filed on August 15, 2014, and Amendment No. 9 to Schedule 13D filed on March 2, 2016 with respect to the common stock, par value $0.01 per share (the “Common Shares”), of Castle Brands Inc., a Florida corporation and successor by merger to Castle Brands Inc., a Delaware corporation (the “Issuer”), by furnishing the information set forth below. Except as set forth below, all previous Items are unchanged. Capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Original 13D, as amended.

 

Based on the most recently disclosed number of outstanding Common Shares, the Reporting Persons are filing this Amendment to report a decrease in their respective current beneficial ownership percentages of the Issuer’s Common Shares, resulting solely from an increase in the number of outstanding Common Shares.

 

Item 1. Security and Issuer

 

Item 1 is hereby deleted in its entirety and replaced with the following:

 

This statement on Schedule 13D (this “Schedule 13D”) relates to the common stock, par value $0.01 per share (the “Common Shares”), of Castle Brands Inc., a Florida corporation (the “Issuer”). The principal executive offices of the Issuer are located at 122 East 42nd Street, Suite 5000, New York, New York 10168.

 

Item 5. Interest in Securities of the Issuer

 

(a) and (b) Items 5(a) and 5(b) are hereby deleted in their entirety and replaced with the following:

 

The Reporting Persons beneficially own Common Shares as follows:

 

Name		Number of Common Shares				Sole or Shared Voting		Sole or Shared Dispositive		% of Total Outstanding
Phillip Frost, M.D.			874,776	(1)		Sole		Sole			0.5	%(2)
			53,271,509	(3)(4)		Shared(5)(6)		Shared(5)(6)			32.1	%(7)
Total:			54,146,285	(1)(3)(4)							32.6	%(8)
Frost Gamma Investments Trust			43,900,719	(3)		Shared(5)		Shared(5)			26.4	%(7)
Frost Nevada Investments Trust			9,370,790			Shared(6)		Shared(6)			5.6	%(7)

 

 

CUSIP No. 148435100

13D/A

Page 6 of 7 Pages

 

(1) Includes (i) vested options (including options that will be exercisable within 60 days of the date hereof) to purchase 80,000 Common Shares and (ii) 15,000 restricted Common Shares granted to Frost on March 1, 2018, which will vest in two equal annual installments, beginning on the one year anniversary of the date of grant.

 

(2) The calculation of the percentage is based on (i) 166,141,838 Common Shares outstanding as of February 7, 2018, as reported on the 10-Q filed on February 9, 2018, (ii) 80,000 Common Shares to be issued upon the exercise of vested options (including options that will be exercisable within 60 days of the date hereof) held by the Reporting Person and (iii) 15,000 restricted Common Shares granted to Frost on March 1, 2018, which will vest in two equal annual installments, beginning on the one year anniversary of the date of grant.

 

(3) Includes 43,900,719 Common Shares held by the Gamma Trust.

 

(4) Includes 9,370,790 Common Shares held by the Nevada Trust.

 

(5) Frost is the sole trustee of the Gamma Trust and may be deemed to share beneficial ownership of the securities held by the Gamma Trust with the Gamma Trust. Frost Gamma Limited Partnership is the sole and exclusive beneficiary of the Gamma Trust. Frost is one of two limited partners of Frost Gamma Limited Partnership. The general partner of Frost Gamma Limited Partnership is Frost Gamma, Inc. and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation.

 

(6) Frost is the sole trustee of the Nevada Trust and may be deemed to share beneficial ownership of the securities held by the Nevada Trust with the Nevada Trust. Frost-Nevada Limited Partnership is the sole and exclusive beneficiary of the Nevada Trust. Frost is one of five limited partners of Frost-Nevada Limited Partnership and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada Limited Partnership.

 

(7) The calculation of the percentage is based on 166,141,838 Common Shares outstanding as of February 7, 2018, as reported on the 10-Q filed on February 9, 2018.

 

(8) The calculation of the percentage is based on (i) 166,141,838 Common Shares outstanding as of February 7, 2018, as reported on the 10-Q filed on February 9, 2018, (ii) 80,000 Common Shares to be issued upon the exercise of vested options (including options that will be exercisable within 60 days of the date hereof) held by the Reporting Person and (iii) 15,000 restricted Common Shares granted to Frost on March 1, 2018, which will vest in two equal annual installments, beginning on the one year anniversary of the date of grant.

 

(c)       Item 5(c) is hereby deleted in its entirety and replaced with the following:

 

During the past 60 days prior to the date hereof, the following transactions occurred:

 

On January 18, 2018, the Gamma Trust converted a $500,000 aggregate principal amount Convertible Note held by the Gamma Trust (including accrued interest) in exchange for 558,179 Common Shares.

 

On March 1, 2018, 15,000 restricted Common Shares were granted to Frost pursuant to a Restricted Stock Agreement, dated as of March 1, 2018, pursuant to the Company’s 2013 Incentive Compensation Plan, as amended. The grant was part of the Issuer’s annual equity grant to its non-management directors; the restricted Common Shares will vest in two equal annual installments, beginning on the one year anniversary of the date of grant.

 

 

CUSIP No. 148435100

13D/A

Page 7 of 7 Pages

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated as of March 16, 2018

 

	/s/ Phillip Frost, M.D.
	Phillip Frost, M.D.

 

	FROST GAMMA INVESTMENTS TRUST
	By:	/s/ Phillip Frost, M.D.
	Name:	Phillip Frost, M.D.
	Title:	Trustee

 

	FROST NEVADA INVESTMENTS TRUST
	By:	/s/ Phillip Frost, M.D.
	Name:	Phillip Frost, M.D.
	Title:	Trustee